103 related articles for article (PubMed ID: 17460398)
1. Increased number of cytotoxic CD3+ CD28- gammadelta T cells in peripheral blood of patients with cutaneous malignant melanoma.
Campillo JA; Martínez-Escribano JA; Minguela A; López-Alvarez R; Marín LA; García-Alonso AM; Bensussan A; Alvarez-López MR
Dermatology; 2007; 214(4):283-8. PubMed ID: 17460398
[TBL] [Abstract][Full Text] [Related]
2. Persistent ex vivo low number and functional in vitro recovery of circulating gammadelta T cells after removal of a cutaneous primary melanoma.
Provinciali M; Re F; Tucci MG; Ricotti F; Lattanzio F
Scand J Immunol; 2010 Aug; 72(2):142-9. PubMed ID: 20618773
[TBL] [Abstract][Full Text] [Related]
3. CD3 bright lymphocyte population reveal gammadelta T cells.
Lambert C; Genin C
Cytometry B Clin Cytom; 2004 Sep; 61(1):45-53. PubMed ID: 15351982
[TBL] [Abstract][Full Text] [Related]
4. Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.
Freysdottir J; Hussain L; Farmer I; Lau SH; Fortune F
Oral Dis; 2006 May; 12(3):271-7. PubMed ID: 16700735
[TBL] [Abstract][Full Text] [Related]
5. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection.
Chen M; Zhang D; Zhen W; Shi Q; Liu Y; Ling N; Peng M; Tang K; Hu P; Hu H; Ren H
J Infect Dis; 2008 Dec; 198(11):1643-50. PubMed ID: 18954265
[TBL] [Abstract][Full Text] [Related]
8. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age.
Simone R; Zicca A; Saverino D
J Leukoc Biol; 2008 Dec; 84(6):1454-61. PubMed ID: 18780874
[TBL] [Abstract][Full Text] [Related]
9. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
[TBL] [Abstract][Full Text] [Related]
10. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of CD28 coincides with the down-modulation of CD3zeta and augmentation of caspase-3 activity in T cells from hepatocellular carcinoma-bearing patients and hepatitis C virus-infected patients.
Maki A; Matsuda M; Asakawa M; Kono H; Fujii H; Matsumoto Y
J Gastroenterol Hepatol; 2004 Dec; 19(12):1348-56. PubMed ID: 15610307
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
[TBL] [Abstract][Full Text] [Related]
14. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood gamma-delta T cells in advanced-stage cancer patients.
Bilgi O; Karagoz B; Turken O; Kandemir EG; Ozturk A; Gumus M; Yaylaci M
Adv Ther; 2008 Mar; 25(3):218-24. PubMed ID: 18369538
[TBL] [Abstract][Full Text] [Related]
16. In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma.
Burjanadzé M; Condomines M; Reme T; Quittet P; Latry P; Lugagne C; Romagne F; Morel Y; Rossi JF; Klein B; Lu ZY
Br J Haematol; 2007 Oct; 139(2):206-16. PubMed ID: 17897296
[TBL] [Abstract][Full Text] [Related]
17. Investigation of T cell receptors in the peripheral blood of patients with active pulmonary tuberculosis.
Akbulut HH; Deveci F; Celik I; Ilhan F; Turgut T
Indian J Med Microbiol; 2009; 27(1):40-3. PubMed ID: 19172058
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms for Kv1.3 potassium channel current inhibition by CD3/CD28 stimulation in Jurkat T cells.
Matsushita Y; Ohya S; Itoda H; Kimura T; Suzuki Y; Yamamura H; Imaizumi Y
Biochem Biophys Res Commun; 2008 Sep; 374(1):152-7. PubMed ID: 18611390
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
[TBL] [Abstract][Full Text] [Related]
20. [A comparison of the morphofunctional characteristics of the peripheral blood lymphocytes and the immune status of patients with malignant melanoma of the skin].
Naleskina LA; Ganina KP; Labunets IF; Grinevich IuA; Abramenko VA
Tsitol Genet; 1996; 30(5):16-22. PubMed ID: 9026985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
